Save $11.67
Description
Ibrutinib is a medication primarily used in the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It belongs to a class of drugs known as Bruton’s tyrosine kinase (BTK) inhibitors, which work by blocking the activity of BTK, a protein involved in the growth and survival of cancer cells. Ibrutinib is typically taken orally in capsule or tablet form.
| Active Ingredient (Generic Name): | Ibrutinib |
| Manufacturer: | Hetero Healthcare Limited |
| Packaging: | 30 Capsules in 1 bottle |
| Strength: | 140 MG |
| Delivery Time: | 6 To 15 days |
| SKU: | Ibrutinib 140 mg |
Additional information
| Quantity Value (Tablets) | 120 Tablet/s, 150 Tablet/s, 30 Tablet/s, 300 Tablet/s, 60 Tablet/s, 90 Tablet/s |
|---|
Reviews
There are no reviews yet.